Q4 2015 Holdings
Filed 2016-02-11 | 119 holdings | $78.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Smith A O(AOS) | COM | 831865209 | $207 | 2,700 | 0.0% |
| Israel Chemicals LTD(ICL) | SHS | M5920A109 | $280 | 69,083 | 0.0% |
| Genvec Inc | COM NEW | 37246C307 | $343 | 186,500 | 0.0% |
| Atyr Pharma Inc(LIFEUSD) | COM | 002120103 | $358 | 36,450 | 0.0% |
| Ezchip Semiconductor Limited | ORD | M4146Y108 | $505 | 20,447 | 0.0% |
| Catabasis Pharmaceuticals in | COM | 14875P107 | $640 | 80,742 | 0.0% |
| Charter Communications Inc D | CL A NEW | 16117M305 | $737 | 4,026 | 0.0% |
| WIX COM LTD(WIX) | SHS | M98068105 | $807 | 35,460 | 0.0% |
| Ellomay Capital Limited(ELLO) | SHS | M39927120 | $824 | 95,653 | 0.0% |
| Delphi Automotive PLC | SHS | G27823106 | $863 | 10,065 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $907 | 215,000 | 0.0% |
| Wabtec Corp(WAB) | COM | 929740108 | $908 | 12,761 | 0.0% |
| Mannkind CorpCall | CALL | 56400P901 | $1.1K | 760,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.3K | 45,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $1.3K | 150,000 | 0.0% |
| Carbylan Therapeutics Inc | COM | 141384107 | $1.3K | 360,000 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $1.4K | 181,818 | 0.0% |
| NXP Semiconductors N V(NXPI) | COM | N6596X109 | $1.4K | 16,920 | 0.0% |
| Axalta Coating SYS LTD(AXTA) | COM | G0750C108 | $1.5K | 56,173 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $1.5K | 157,500 | 0.0% |
| Novartis A G(NVSN) | SPONSORED ADR | 66987V109 | $1.5K | 18,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $1.6K | 30,686 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $1.7K | 23,790 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.7K | 132,300 | 0.0% |
| Ocera Therapeutics Inc | COM | 67552A108 | $1.7K | 550,000 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $1.8K | 231,548 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $1.9K | 810,000 | 0.0% |
| Tobira Therapeutics Inc | COM | 88883P101 | $1.9K | 187,622 | 0.0% |
| Scynexis Inc | COM | 811292101 | $1.9K | 304,600 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $1.9K | 155,000 | 0.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $2.0K | 220,000 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $2.0K | 600,000 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $2.1K | 134,037 | 0.0% |
| Palatin Technologies Inc | COM PAR $ .01 | 696077403 | $2.1K | 3,132,926 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $2.1K | 66,020 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $2.2K | 120,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $2.2K | 90,000 | 0.0% |
| Cognizant Technology Solutio(CTSH) | CL A | 192446102 | $2.2K | 36,600 | 0.0% |
| Medicines Co | COM | 584688105 | $2.2K | 60,000 | 0.0% |
| Dimension Therapeutics Inc | COM | 25433V105 | $2.3K | 200,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $2.3K | 121,500 | 0.0% |
| Summit Therapeutics PLC | SPONS ADS | 86627R102 | $2.3K | 202,220 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $2.3K | 135,000 | 0.0% |
| Advance Auto Parts Inc(AAP) | COM | 00751Y106 | $2.3K | 15,555 | 0.0% |
| Colucid Pharmaceuticals Inc | COM | 19716T101 | $2.4K | 285,525 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $2.5K | 450,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.5K | 153,500 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.6K | 48,400 | 0.0% |
| Retrophin Inc | COM | 761299106 | $2.6K | 135,000 | 0.0% |
| Honeywell Intl Inc(HON) | COM | 438516106 | $2.7K | 25,595 | 0.0% |